EUVIMEDDescoperă EUVIMED
Crossref

Effect of the opioid crisis on the liver transplantation donor pool: A national analysis

Yutaka Endo, Kazunari Sasaki, Muhammad Musaab Munir, Selamawit Woldesenbet, Diamantis I Tsilimigras, Erryk Katayama, Jason Yang, Ashley Limkemann iD, Austin Schenk, Kenneth Washburn, Timothy M Pawlik iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15290 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Yutaka Endo and 10 co-authors. Institution: Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA. Major MEDLINE topics: Liver Transplantation, Drug Overdose, COVID-19. Cited 1 times so far (Crossref); 32 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Over the last decade there has been a surge in overdose deaths due to the opioid crisis. We sought to characterize the temporal change in overdose donor (OD) use in liver transplantation (LT), as well as associated post‐LT outcomes, relative to the COVID‐19 era.

Methods

LT candidates and donors listed between January 2016 and September 2022 were identified from the Scientific Registry of Transplant Recipients database. Trends in LT donors and changes related to OD were assessed pre‐ versus post‐COVID‐19 (February 2020).

Results

Between 2016 and 2022, most counties in the United States experienced an increase in overdose‐related deaths ( n = 1284, 92.3%) with many counties ( n = 458, 32.9%) having more than a doubling in drug overdose deaths. Concurrently, there was an 11.2% increase in overall donors, including a 41.7% increase in the number of donors who died from drug overdose. In pre‐COVID‐19 overdose was the 4th top mechanism of donor death, while in the post‐COVID‐19 era, overdose was the 2nd most common cause of donor death. OD was younger (OD: 35 yrs, IQR 29–43 vs. non‐OD: 43 yrs, IQR 31–56), had lower body mass index (≥35 kg/cm 2 , OD: 31.2% vs. non‐OD: 33.5%), and was more likely to be HCV+ (OD: 28.9% vs. non‐OD: 5.4%) with lower total bilirubin (≥1.1 mg/dL, OD: 12.9% vs. non‐OD: 20.1%) (all p < .001). Receipt of an OD was not associated with worse graft survival (HR .94, 95% CI .88–1.01, p = .09).

Conclusions

Opioid deaths markedly increased following the COVID‐19 pandemic, substantially altering the LT donor pool in the United States.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationDrug OverdoseCOVID-19HumansUnited StatesOpioid EpidemicPandemicsTissue Donors

Author keywords

organ allocationregistry/registry analysisscientific registry for transplant recipients (SRTR)

Authors and institutions

  • Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Department of Surgery, Stanford University, Stanford, California, USA.

ORCID profiles: Ashley Limkemann, Timothy M Pawlik

Cite

APA

Endo, Y., Sasaki, K., Munir, M. M., Woldesenbet, S., Tsilimigras, D. I., Katayama, E., Yang, J., Limkemann, A., Schenk, A., Washburn, K., & Pawlik, T. M. (2024). Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. https://doi.org/10.1111/ctr.15290

Vancouver

Endo Y, Sasaki K, Munir MM, Woldesenbet S, Tsilimigras DI, Katayama E, et al. Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. 2024. doi:10.1111/ctr.15290

BibTeX
@article{Endo2024,
  author = {Endo, Yutaka and Sasaki, Kazunari and Munir, Muhammad Musaab and Woldesenbet, Selamawit and Tsilimigras, Diamantis I and Katayama, Erryk and Yang, Jason and Limkemann, Ashley and Schenk, Austin and Washburn, Kenneth and Pawlik, Timothy M},
  title = {Effect of the opioid crisis on the liver transplantation donor pool: A national analysis},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15290}
}
Start for free →